NuSight Medical Announces Issuance of U.S. Patent Covering the NuLids System® for Treating Dry Eye Disease

LG Thin-Clients Feature Built-in RFID Capabilities Optimized for Use in Healthcare Facilities

Supporting its mission to help healthcare providers streamline operations and deliver exceptional patient care, LG Business Solutions USA introduced a new LG thin client...

Experien Group Acquired by Veranex

Veranex combines product development, regulatory, and market access expertise — globally and across complex and emerging markets.

NuSight Medical a medical device company focused on the doctor directed, at-home treatment of dry eye disease to address significant unmet needs in ophthalmic and optometric eye care, today announced that the U.S. Patent Office has issued Patent No. 10,314,763, which is directed to methods related to the treatment of Dry Eye Disease.

U.S. Patent No. 10,314,763 covers the use of the NuLids System treatment for the treatment of dry eye/ocular surface disease, blepharitis and related conditions. “The patent protects our entire NuLids system – the device and methods for its use, the disposable soft-tips, and product safety features” said Robert Foster, CEO of NuSight Medical.

All 29 claims were approved providing key declarations that involve stimulating the Meibomian glands to effectively treat dry eye. The following is excerpted directly from the abstract:

“ … an improved eyelid care appliance and method of using such appliance for preventing and treating blepharitis and mammalian meibomian gland dysfunction caused by gland obstruction. The method and apparatus of the invention enable restoration and maintenance of eyelid hygiene and the natural flow of secretions from the meibomian glands … ”

NuLids treats the predominate cause of Dry Eye Disease, Meibomian Gland Dysfunction, at home every day, which is not practical with in-office treatments. NuLids has brought the highly successful dental model to eyecare. Patients visit their dentist for a deep cleaning and other services that must be professionally performed and then maintain and improve their oral health by brushing and flossing daily while at home. NuLids brings that same paradigm to eye care. Doctors continue to provide office-based dry eye services and patients participate in their continued care by using the clinically validated NuLids System from home,” said John Olkowski, MD, cornea specialist and the inventor of NuLids.

“NuLids is flourishing because it addresses multiple problems for doctors and their patients.” added Foster. “Our professional customers and their patients report excellent results. Doctors benefit from happier, better served patients, and new revenue streams. And, patients look, feel, and see better while maintaining or reducing the cost of treating their disease.”

NuSight Medical has additional patent applications pending.



Graham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders

At Advanced Clinical, and from previous organizations, Belgrave serves as a mentor to several colleagues, where he challenges them to think outside of the box and take risks.

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.